London UK (February, 16 - 17, 2015)
RNA Therapeutics 2015 returns to London on 16th and 17th February, gathering a room full of scientific pioneers and industry experts to identify the latest advancements, best practice and strategies to maximise return on investment.
The cutting edge event will ask questions such as:
What are the current opportunities, obstacles and solutions for developing effective RNAi based drugs? What makes CRISPR-Cas special and how can be used as a role model for personalised medicine? Why use a patent to protect a biotech innovation? How do we unlock the potential with locked nucleic acid? How does the next generation of ASOs demonstrate robust target knock down in multiple preclinical cancer models?
Hear case study driven presentations from an array of market leaders such as Roche, CRISPR Therapeutics, Leiden University Medical Centre, MiNa Therapeutics and AstraZeneca, discussing the latest advancements and programmes, CRIPSPR gene editing technologies, hepatic targeting, viral delivery, the patent application process, RNA splicing, plus much more!
KEY SPEAKERS
REASONS TO ATTEND
To register or for further details, visit http://www.therapeutics-rna.com/
Alternatively contact the team on +44 (0) 870 9090 711 or email events@smi-online.co.uk
More: www.therapeutics-rna.com
Gate2Biotech - Biotechnology Portal - All Czech Biotechnology information in one place.
ISSN 1802-2685
This website is maintained by: CREOS CZ
© 2006 - 2024 South Bohemian Agency for Support to Innovative Enterprising (JAIP)
Interesting biotechnology content:
Biotechnology Books no. 14 - 14th page of aour database of biotechnology books
DNA - Deoxyribonucleic acid (DNA) at Wikipedia
New fuel cell harvests energy from microbes in soil to power sensors, communications
Marine algae implants could boost crop yields